Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: A retrospective study Academic Article uri icon

Overview

MeSH Major

  • Endometrial Neoplasms

abstract

  • TC is a well tolerated, active regimen in the treatment of resected, high-risk stage III and IV endometrial cancer that warrants further investigation.

publication date

  • November 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2006.03.019

PubMed ID

  • 16677690

Additional Document Info

start page

  • 451

end page

  • 7

volume

  • 103

number

  • 2